Indexing
CÁC SỐ TỪ 2011-2023
Tạp chí Y Dược Học
Tóm tắt
Background: Enterococcus faecalis (E. faecalis) is commonly implicated in persistent endodontic infections and has been identified as a major contributor to endodontic treatment failure. Due to the complex anatomy of the root canal system and the persistent bacterial colonization, mechanical preparation alone is often insufficient to completely eliminate bacteria and their toxins. Therefore, the present study aimed to evaluate the antibacterial efficacy of endodontic irrigating solutions.
Objective: To evaluate and compare the antibacterial efficacy of 5.25% Sodium hypochlorite (NaOCl), 2% Chlorhexidine (CHX), and a surfactant-modified 2% Chlorhexidine (CHX Plus™) against E. faecalis biofilms in an in vitro model.
Materials and Methods: An in vitro study was conducted on 66 human mandibular premolars, which were divided into four groups: 5.25% NaOCl, 2% CHX, 2% CHX Plus™, and a negative control group (0.9% NaCl). The root canals were prepared to a master apical file size of #40 and step-back to #80. The samples were inoculated with E. faecalis (ATCC 29212) and incubated for 7 days to allow early biofilm formation. The teeth were then irrigated, the remaining bacteria were collected, and bacterial counts were quantified by colony-forming unit (CFU/mL) enumeration. Data were analyzed using Kruskal–Wallis and Mann–Whitney U tests (p < 0.05).
Results: All experimental irrigants significantly reduced the bacterial load compared to the negative control group (p < 0.001). Both 5.25% NaOCl and 2% CHX Plus™ demonstrated significantly higher antibacterial activity compared to conventional 2% CHX (p < 0.05). No statistically significant difference was observed between the NaOCl and CHX Plus™ groups (p > 0.05), although NaOCl showed the lowest absolute residual bacterial counts.
Conclusion: All three solutions showed high antibacterial efficacy against E. faecalis. However, 2% CHX was less effective than 5.25% NaOCl and 2% CHX Plus™.
| Đã xuất bản | 25-08-2026 | |
| Toàn văn |
|
|
| Ngôn ngữ |
|
|
| Số tạp chí | Tập 16 Số 04 (2026) | |
| Phân mục | Nghiên cứu | |
| DOI | 10.34071/jmp.2026.4.1066 | |
| Từ khóa | lisinopril; amlodipine besylate; high performance liquid chromatography; simultaneous determination |
công trình này được cấp phép theo Creative Commons Attribution-phi thương mại-NoDerivatives 4.0 License International .
Bản quyền (c) 2026 Tạp chí Y Dược Huế
Hypertension. World Health Organization. October 21, 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension.
McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). European Heart Journal. 2024;45(38):3913-3921. doi:10.1093/eurheartj/ehae178.
Chauhan V, Prajapati ST, Patel CN. A validated RP-HPLC method for simultaneous estimation of amlodipine and lisinopril in pharmaceutical dosage form. Int J Pharm Sci Res. 2011;2(7):1712-1715. doi:10.13040/IJPSR.0975-8232.2(7).1712-15.
Shelke S, Patil B, Kukade V, Chandrakantkewari C. Analytical method development and validation of RP-HPLC for amlodipine besylate and lisinopril in combined tablet dosage form by using simultaneous estimation method. JASR. 2023;14(07):63-68. doi:10.55218/JASR.202314710.
Piponski M, Stoimenova TB, Serafimovska GT, Stefova M. Development and validation of fast, simple, cost-effective and robust RP-HPLC method for simultaneous determination of lisinopril and amlodipine in tablets. Anal Chem Lett. 2019;9(3):385-402. doi:10.1080/22297928.2019.1650108.
Babar SA, Padwal SL, Bachute MT. QbD based RP-HPLC method development and validation for simultaneous estimation of amlodipine besylate and lisinopril dihydrate in bulk and pharmaceutical dosage form. JPRI. 2021;33(43A):143-164. doi:10.9734/jpri/2021/v33i43A32474.
Aldewachi H. Simultaneous determination of lisinopril and amlodipine using third derivative spectroscopy. Baghdad Sci J. 2024. doi:10.21123/bsj.2024.9893.
Beema JS, Dhruvi AP, Krishana KS, Sushant KS, Priyadasini R, Durgadevi G, et al. Stability-indicating RP-HPLC method for the quantitative determination of amlodipine besylate and lisinopril in combined antihypertensive formulations. Int J Environ Sci. 2025;11:3871.
International Council for Harmonisation (ICH). ICH Harmonised Guideline: Validation of Analytical Procedures Q2(R2). 2023.
Hussein J. Principles and applications of high-performance liquid chromatography (HPLC): A review. Biomed Pharmacol J. 2025;18(2).
Remko M. Acidity, lipophilicity, solubility, absorption, and polar surface area of some ACE inhibitors. Chem Pap. 2007;61(2):133-141. doi:10.2478/s11696-007-0010-y.
Dennison TJ, Smith J, Badhan RKS, Mohammed AR. Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability. Drug Des Devel Ther. 2017;11:811-826. doi:10.2147/DDDT.S126035.
LCGC International. The LCGC Blog: Silica for HPLC stationary phases – a five minute guide. May 23, 2026. Available from: https://www.chromatographyonline.com/view/lcgc-blog-silica-hplc-stationary-phases-five-minute-guide-0.